Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Roses

Showing results (11-20 of 347) with videos related to

Pageof 35
Sort By:
Neurobiology of Disease|January 1, 1997
Apolipoprotein E, a gene with complex biological interactions in the aging brainA D Roses
Annals of the New York Academy of Sciences|December 16, 1996
Apolipoprotein E and Alzheimer's disease. A rapidly expanding field with medical and epidemiological consequencesA D Roses
Current Opinion in Neurobiology|October 1, 1996
The Alzheimer diseasesA D Roses
Alzheimer Disease and Associated Disorders|January 7, 1999
Genetic testing and Alzheimer disease: the promiseA D Roses
Annals of the New York Academy of Sciences|February 4, 1999
Apolipoprotein E and Alzheimer's disease. The tip of the susceptibility icebergA D Roses
Archives of Internal Medicine|August 1, 1985
Myotonic muscular dystrophy. From clinical description to molecular geneticsA D Roses
Lancet (London, England)|April 25, 2000
Pharmacogenetics and future drug development and deliveryA D Roses
Archives of Neurology|November 16, 2001
2025: the practice of neurology: back from the futureA D Roses
Drug Discovery Today|February 13, 2001
How will pharmacogenetics impact the future of research and development?A D. Roses
Journal of Neuropathology and Experimental Neurology|September 1, 1994
Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of diseaseA D Roses
Pageof 35

Showing results (11-20 of 347) with videos related to

Sort By:
Pageof 35
Neurobiology of Disease|January 1, 1997
Apolipoprotein E, a gene with complex biological interactions in the aging brainA D Roses
Annals of the New York Academy of Sciences|December 16, 1996
Apolipoprotein E and Alzheimer's disease. A rapidly expanding field with medical and epidemiological consequencesA D Roses
Current Opinion in Neurobiology|October 1, 1996
The Alzheimer diseasesA D Roses
Alzheimer Disease and Associated Disorders|January 7, 1999
Genetic testing and Alzheimer disease: the promiseA D Roses
Annals of the New York Academy of Sciences|February 4, 1999
Apolipoprotein E and Alzheimer's disease. The tip of the susceptibility icebergA D Roses
Archives of Internal Medicine|August 1, 1985
Myotonic muscular dystrophy. From clinical description to molecular geneticsA D Roses
Lancet (London, England)|April 25, 2000
Pharmacogenetics and future drug development and deliveryA D Roses
Archives of Neurology|November 16, 2001
2025: the practice of neurology: back from the futureA D Roses
Drug Discovery Today|February 13, 2001
How will pharmacogenetics impact the future of research and development?A D. Roses
Journal of Neuropathology and Experimental Neurology|September 1, 1994
Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of diseaseA D Roses
Pageof 35